Mechanism-based candidate inhibitors of uridine diphosphate galactopyranose mutase (UGM)

被引:2
|
作者
Mahdavi-Amiri, Yasaman [1 ]
Mohan, Sankar [1 ]
Borrelli, Silvia [1 ]
Slowski, Kathryn [2 ]
Sanders, David A. R. [2 ]
Pinto, B. Mario [1 ]
机构
[1] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada
[2] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Enzyme inhibitors; Mycobacterium tuberculosis; Synthesis; Transition-state analogues; UDP-galactopyranose mutase; UGM; STD-NMR SPECTROSCOPY; UDP-GALACTOPYRANOSE; GLUCOSIDASE INHIBITORS; STEREOSELECTIVE-SYNTHESIS; BIOLOGICAL EVALUATION; ESCHERICHIA-COLI; STRUCTURAL BASIS; SUBSTRATE; BINDING; ANALOGS;
D O I
10.1016/j.carres.2015.10.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uridine diphosphate-galactopyranose mutase (UGM), an enzyme found in many eukaryotic and prokaryotic human pathogens, catalyzes the interconversion of UDP-galactopyranose (UDP-Galp) and UDP-galactofuranose (UDP-Galf), the latter being used as the biosynthetic precursor of the galactofuranose polymer portion of the mycobacterium cell wall. We report here the synthesis of a sulfonium and selenonium ion with an appended polyhydroxylated side chain. These compounds were designed as transition state mimics of the UGM-catalyzed reaction, where the head groups carrying a permanent positive charge were designed to mimic both the shape and positive charge of the proposed galactopyranosyl cation-like transition state. An HPLC-based UGM inhibition assay indicated that the compounds inhibited about 25% of UGM activity at 500 mu M concentration. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] Mechanism-based inactivation of benzoylformate decarboxylase, a thiamin diphosphate-dependent enzyme
    Bera, Asim K.
    Polovnikova, Lena S.
    Roestamadji, Juliatek
    Widlanski, Theodore S.
    Kenyon, George L.
    McLeish, Michael J.
    Hasson, Miriam S.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (14) : 4120 - +
  • [32] Kinetic characterization and optimization of mechanism-based inhibitors of BioA
    Eiden, Carter
    Aldrich, Courtney
    Lipscomb, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [33] THE INTERACTION OF MECHANISM-BASED INHIBITORS WITH MONOAMINE-OXIDASE
    ANDERSON, MC
    BACKWELL, C
    WILLIAMS, CH
    TIPTON, KF
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1987, 15 (02) : 244 - 245
  • [34] VINYL SULFONES AS MECHANISM-BASED CYSTEINE PROTEASE INHIBITORS
    PALMER, JT
    RASNICK, D
    KLAUS, JL
    BROMME, D
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) : 3193 - 3196
  • [35] HDAC inhibitors: Clinical update and mechanism-based potential
    Glaser, Keith B.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (05) : 659 - 671
  • [36] Novel, selective mechanism-based inhibitors of the herpes proteases
    Pinto, IL
    West, A
    Debouck, CM
    DiLella, AG
    Gorniak, JG
    ODonnell, KC
    OShannessy, DJ
    Patel, A
    Jarvest, RL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (20) : 2467 - 2472
  • [37] MECHANISM-BASED INHIBITORS OF DOPAMINE-BETA-HYDROXYLASE
    VILLAFRANCA, JJ
    COLOMBO, G
    RAJASHEKHER, B
    FITZPATRICK, P
    FLORY, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 108 - BIOL
  • [38] MECHANISM-BASED INHIBITORS OF DOPAMINE BETA-HYDROXYLASE
    FITZPATRICK, PF
    VILLAFRANCA, JJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1987, 257 (02) : 231 - 250
  • [39] MECHANISM-BASED INHIBITORS OF DOPAMINE BETA-HYDROXYLASE
    VILLAFRANCA, JJ
    COLOMBO, G
    RAJASHEKHER, B
    FITZPATRICK, P
    FLORY, D
    BIOCHEMISTRY, 1984, 23 (14) : 3366 - 3366
  • [40] αβ,α′β′-Diepoxyketones are mechanism-based inhibitors of nucleophilic cysteine enzymes
    de Munnik, Mariska
    Lithgow, Jasper
    Brewitz, Lennart
    Christensen, Kirsten E.
    Bates, Robert H.
    Rodriguez-Miquel, Beatriz
    Schofield, Christopher J.
    CHEMICAL COMMUNICATIONS, 2023, 59 (86) : 12859 - 12862